Inside Vector Bioscience: TechTales of Innovation #2

Tech Tales #2 Exploring MOF Nanoshuttles

At Vector Bioscience Cambridge, our mission is to advance drug delivery technologies for more effective and targeted treatments. In this second post of our Tech Tales series, we delve into the science behind the MOF-based nanoshuttles that form the core of our platform technology.

Metal-Organic Frameworks (MOFs) are materials made by repeating a unit cell to create a highly porous network. This structure enables exceptional adsorption properties, making MOFs ideal for encapsulating therapeutic cargoes. The large internal surface area and tunable chemistry of these materials provide significant advantages in drug delivery.

At Vector, we utilise the porosity of MOFs to encapsulate a range of therapeutic agents, from small molecules to macromolecules, including peptides, proteins, and RNA. This adaptability ensures that our platform is versatile and can be applied to diverse medical needs.

Our MOF nanoshuttles are designed to optimise drug delivery by increasing the loading capacity of therapeutic agents and ensuring their stability throughout the process. This approach supports the development of innovative cancer treatments, allowing precise delivery of drugs directly to their intended targets while reducing potential side effects.

We are committed to harnessing cutting-edge science to improve patient outcomes. Stay tuned for the next instalment of our Tech Tales series, where we continue to explore the breakthroughs driving our MOF-based drug delivery platform.

Join us on this journey to revolutionise healthcare!

Share the Post:
Scroll to Top